Celldex Therapeutics, Inc. License Agreements
7 Contracts & Agreements
- Amended and Restated License Agreement by and between the Company and Yale University dated as of July 26, 2022 (Filed With SEC on November 9, 2022)
- Third Amended and Restated License Agreement by and between Yale University and the Company, dated March 14, 2013, as amended by the Amendments, dated March 21, 2014 and December... (Filed With SEC on March 7, 2018)
- License and Option Agreement by and between MedImmune, LLC and the Company, dated July 24, 2013, as amended by the Amendment, dated October 27, 2015 (Filed With SEC on March 7, 2018)
- Exclusive Patent And Know-How License Agreement (Filed With SEC on March 2, 2009)
- ASSIGNMENTAND LICENSE AGREEMENT (Filed With SEC on September 22, 2004)
- ASSIGNMENTAND LICENSE AGREEMENT (Filed With SEC on August 16, 2004)
- Confidential Treatment Requested As To Certain Information Contained InThis Exhibit NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on April 30, 2004)
